Allergist/Immunologist Bidzina Kulumbgov says in his Facebook post that Pfizer's effectiveness against the Omicron coronavirus variant has reduced 40% but its protection level against hospitalization and death remains high.
''Get your jabs,'' Kulumbegov says.